ProFibrix develops and markets medicinal products for hemostasis and regenerative.
Business Model:
Revenue: $10.3M
Employees: 51-200
ProFibrix was acquired by
The Medicines Company.
The acquisition happend on 2013-08-05.
Details of the transaction were not public
Address: Darwinweg 24
City: Leiden
State: other
Zip: 2333 CK
Country: NL
ProFibrix develops and markets medicinal products for hemostasis and regenerative.
Contact Phone:
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|
Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 8/2011 | Series B | 4 | $10.6M |
Gilde Healthcare Index Ventures Inkef Vesalius Biocapital Partners Gilde Healthcare Index Ventures Inkef Vesalius Biocapital Partners |
8/2009 | Series B | 1 | $11.4M |
Gilde Healthcare Gilde Healthcare |
3/2007 | Series A | 1 | $11M |
Index Ventures Index Ventures |
---|
Announced Date | Name | Price |
---|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|